Blue Owl Capital Holdings »

Aktis Oncology shares owned by Blue Owl Capital Holdings

Quarter-by-quarter ownership of Aktis Oncology shares owned by Blue Owl Capital Holdings from 13F filings

Historical chart of Blue Owl Capital Holdings investment in Aktis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Aktis Oncology held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aktis Oncology by Blue Owl Capital Holdings

Quarter filed Position value Share count Share price at filing
2026-03-31 $57M 3.2M 17.89

More positions owned by Blue Owl Capital Holdings

Aktis Oncology
Larimar Therapeutics (LRMR)
Engene Holdings (ENGN)
Nuveen Churchill Direct Lend Com Shs (NCDL)
Cullinan Oncology (CGEM)
Owl Rock Capital Corporation (OBDC)
Maplight Therapeutics (MPLT)
Compass Therapeutics (CMPX)
Context Therapeutics (CNTX)
Holley (HLLY)
Eyepoint Com New (EYPT)
Corvus Pharmaceuticals (CRVS)
Conduent Incorporate (CNDT)
Ultragenyx Pharmaceutical (RARE)
Aquestive Therapeutics (AQST)

View all positions for Blue Owl Capital Holdings

Top funds holding Aktis Oncology

MPM Oncology Impact Management
EcoR1 Capital
Blue Owl Capital Holdings
Wellington Management Company
BlackRock
Rtw Investments
RA Capital Management
Henderson Group
Baker Bros. Advisors
Octagon Capital Advisors
Merck & Co
Vanguard Capital Management
Eventide Asset Management
Geode Capital Management
Avidity Partners Management

View all funds holding Aktis Oncology